109 results on '"Shimozaki, Keitaro"'
Search Results
2. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer
3. Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan
4. Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases
5. WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)
6. 5-Fluorouracil plus L-leucovorin and oxaliplatin treatment for esophageal squamous cell carcinoma: A multicenter retrospective study
7. ASO Visual Abstract: Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases
8. Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis
9. The effectiveness of palliative care via video telemedicine for patients with advanced cancer: A non-randomized prospective clinical trial
10. The impact of palliative care via video telemedicine: A prospective study
11. A scoring system for selecting nivolumab or irinotecan in the later-line chemotherapy for advanced gastric cancer: A Japanese multicenter retrospective study.
12. Efficacy and safety of trastuzumab deruxtecan and nivolumab as third- or later-line treatment for HER2-positive advanced gastric cancer: A single-institution retrospective study.
13. Subgroup analyses of the effect of ramucirumab in pretreatment with immune checkpoint inhibitor in RINDBeRG: A randomized clinical trial in third- or further-line treatment of gastric cancer.
14. Ulcerative colitis exacerbation after the onset of immune checkpoint inhibitor related colitis
15. Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors
16. MO39-4 Efficacy and safety of trifluridine/tipiracil as a salvage-line treatment for patients with advanced gastric cancer
17. P57-2 Retrospective study of second-line FOLFOX versus S1 for advanced biliary tract cancer
18. Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis
19. Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.
20. Current Strategy to Treat Immunogenic Gastrointestinal Cancers: Perspectives for a New Era
21. The impact of palliative care via video telemedicine: A prospective study
22. Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series
23. Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study
24. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer
25. Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan
26. Clinical impact of DNA methylation status on first-line antiepidermal growth factor receptor treatment in patients with metastatic colorectal cancer.
27. KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer
28. Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018
29. Clinical usefulness of postoperative serum carcinoembryonic antigen in colorectal cancer patients with liver metastases.
30. WJOG13219G: Triplet versus doublet in patients with previously untreated BRAFV600E-mutant metastatic colorectal cancer: A multi-institutional real-world data analysis (BRACELET study).
31. Association of disease progression pattern during third-line chemotherapy with nivolumab with poor prognosis in advanced gastric cancer: A multicenter retrospective study in Japan.
32. Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia.
33. Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer
34. Clinical Impact of Primary Tumor Location and RAS, BRAF V600E, and PIK3CA Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer
35. Real-world Concordance in Microsatellite Instability Status Between PCR-based Testing and Next-Generation Sequencing Assay for Solid Tumors
36. Multiple immune-related adverse events and anti-tumor efficacy: real-world data on various solid tumors
37. The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study
38. Ulcerative colitis exacerbation after the onset of immune checkpoint inhibitor related colitis
39. Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis
40. Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors
41. Hyperprogressive disease during nivolumab chemotherapy in metastatic gastric cancer: Multicenter retrospective study in Japan.
42. Analysis of risk factors for immune-related adverse events in various solid tumors using real-world data.
43. A case report of severe amoebic pancolitis with wide range of ulcerative lesion
44. A retrospective study of immune-related adverse events in various solid tumors
45. Clinical response to subsequent chemotherapy after nivolumab in patients with advanced gastric cancer
46. A case of stacked common bile duct stones with interesting clinical outcomes
47. P2-199 - A retrospective study of immune-related adverse events in various solid tumors
48. P1-022 - Clinical response to subsequent chemotherapy after nivolumab in patients with advanced gastric cancer
49. Removal of gastrointestinal foreign bodies (fish bones) by endoscopy
50. [Ⅰ. Systemic Chemotherapy for Metastatic Colorectal Cancer -Japanese Society for Cancer of the Colon and Rectum(JSCCR)Guidelines 2024 for Treatment of Colorectal Cancer].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.